As of 2025-07-09, the EV/EBITDA ratio of Cue Biopharma Inc (CUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CUE's latest enterprise value is 45.47 mil USD. CUE's TTM EBITDA according to its financial statements is -40.82 mil USD. Dividing these 2 quantities gives us the above CUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.2x | 12.8x |
| Forward P/E multiples | 17.1x - 32.0x | 20.6x |
| Fair Price | (9.15) - (7.00) | (8.92) |
| Upside | -1347.7% - -1055.0% | -1316.7% |
| Date | EV/EBITDA |
| 2025-07-03 | -1.04 |
| 2025-07-02 | -1.04 |
| 2025-07-01 | -1.00 |
| 2025-06-30 | -1.02 |
| 2025-06-27 | -1.13 |
| 2025-06-26 | -1.22 |
| 2025-06-25 | -1.21 |
| 2025-06-24 | -1.10 |
| 2025-06-23 | -0.97 |
| 2025-06-20 | -1.05 |
| 2025-06-18 | -0.97 |
| 2025-06-17 | -0.83 |
| 2025-06-16 | -0.85 |
| 2025-06-13 | -0.87 |
| 2025-06-12 | -0.93 |
| 2025-06-11 | -0.94 |
| 2025-06-10 | -0.93 |
| 2025-06-09 | -0.94 |
| 2025-06-06 | -0.94 |
| 2025-06-05 | -0.92 |
| 2025-06-04 | -0.91 |
| 2025-06-03 | -0.93 |
| 2025-06-02 | -0.97 |
| 2025-05-30 | -0.94 |
| 2025-05-29 | -0.95 |
| 2025-05-28 | -0.92 |
| 2025-05-27 | -0.98 |
| 2025-05-23 | -0.98 |
| 2025-05-22 | -1.07 |
| 2025-05-21 | -0.87 |
| 2025-05-20 | -1.00 |
| 2025-05-19 | -1.07 |
| 2025-05-16 | -1.10 |
| 2025-05-15 | -1.10 |
| 2025-05-14 | -1.14 |
| 2025-05-13 | -1.18 |
| 2025-05-12 | -1.15 |
| 2025-05-09 | -1.20 |
| 2025-05-08 | -1.18 |
| 2025-05-07 | -1.18 |
| 2025-05-06 | -1.15 |
| 2025-05-05 | -1.20 |
| 2025-05-02 | -1.15 |
| 2025-05-01 | -1.15 |
| 2025-04-30 | -1.15 |
| 2025-04-29 | -1.17 |
| 2025-04-28 | -1.22 |
| 2025-04-25 | -1.21 |
| 2025-04-24 | -1.34 |
| 2025-04-23 | -1.30 |